The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II trial of a DNA vaccine encoding prostatic acid phosphatase (pTVG-HP) versus GM-CSF adjuvant in patients with PSA-recurrent prostate cancer.
 
Glenn Liu
Employment - AIQ Solutions
Leadership - AIQ Solutions
Stock and Other Ownership Interests - AIQ Solutions
Consulting or Advisory Role - Exelixis; Janssen; Novartis; Tricon Pharmaceuticals
Research Funding - Johnson & Johnson (Inst); Madison Vaccines, Inc.; Novartis (Inst); Pfizer; TRACON Pharma
Patents, Royalties, Other Intellectual Property - I have patent pending titled "System and method for evaluation of disease burden" which provides a novel method to identify and quantitate treatment response. (Inst)
 
Lawrence Fong
Consulting or Advisory Role - Atreca; BioAtla; Bolt Biotherapeutics; IDEAYA Biosciences; Nutcracker Therapeutics, Inc.; TeneoBio
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Emmanuel S. Antonarakis
Honoraria - Astellas Pharma; AstraZeneca; Clovis Oncology; Dendreon; ESSA; Janssen Biotech; Medivation; Merck; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Clovis Oncology; Dendreon; ESSA; Janssen Biotech; Medivation; Merck; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi
 
Jens C. Eickhoff
Research Funding - Sanofi Pasteur (Inst)
 
Ellen G. Wargowski
No Relationships to Disclose
 
Laura E. Johnson
No Relationships to Disclose
 
Robert Jeraj
Stock and Other Ownership Interests - AIQ Solutions
Research Funding - GE Healthcare
Patents, Royalties, Other Intellectual Property - Several Wisconsin Alumni Research Foundation patents
 
Douglas G. McNeel
Leadership - Madison Vaccines, Inc.
Stock and Other Ownership Interests - Madison Vaccines, Inc.
Consulting or Advisory Role - Genocea Biosciences; GlaxoSmithKline; Madison Vaccines, Inc.
Research Funding - Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen (Inst); Madison Vaccines, Inc.; Madison Vaccines, Inc. (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patents that have been licensed by UW to Madison Vaccines, Inc
Travel, Accommodations, Expenses - Genocea Biosciences; Madison Vaccines, Inc.